Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries

EF Peacocke, LF Heupink, K Frønsdal, EH Dahl… - BMJ open, 2021 - bmjopen.bmj.com
Objective To identify the factors contributing to equitable access to COVID-19 vaccines for
low and middle-income countries (LMIC). Methods We conducted a scoping review …

COVID-19 myocarditis and postinfection Bell's palsy

EH Dahl, KA Mosevoll, D Cramariuc… - … Case Reports CP, 2021 - casereports.bmj.com
Here we present the case of a 37-year-old previously healthy man who developed fever,
headache and a unilateral, painful neck swelling while working offshore. He had no known …

Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway

H Midgard, K Ulstein, Ø Backe, T Foshaug… - International Journal of …, 2021 - Elsevier
Background The aims were to evaluate HCV treatment effectiveness, estimate reinfection
rates, and demonstrate the feasibility of reinfection surveillance and retreatment among …

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C

E Duffell, H Cortez‐Pinto, M Simonova… - Journal of Viral …, 2021 - Wiley Online Library
A goal of the WHO strategy on the elimination of hepatitis as a public threat is a 65%
reduction in the attributable mortality. Deaths related to hepatitis B and C infections are …

Control of visceral leishmaniasis in East Africa: fragile progress, new threats

EH Dahl, HM Hamdan, L Mabrouk… - BMJ Global …, 2021 - gh.bmj.com
Significant progress has been made in reducing the global burden of visceral leishmaniasis
(also known as 'kala azar'), a vectorborne disease that is 100% fatal if left untreated, but new …

DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series

H Zahid, K Aslam, EH Dahl, W Abbassi… - Oxford Medical Case …, 2022 - academic.oup.com
Globally, 58 million people are living with hepatitis C virus (HCV) infection and 1.5 million
new patients are infected every year. The advent of direct acting antivirals (DAAs) has …

[HTML][HTML] Leaving no one behind: Towards equitable global elimination of hepatitis C

EH Dahl, H Zahid, K Aslam, W Jafri - Journal of global health, 2020 - ncbi.nlm.nih.gov
June 2020• Vol. 10 No. 1• 010308 2 www. jogh. org• doi: 10.7189/jogh. 10.010308 al
resurgence in HCV control has been driven by the shared promise of new treatments, and …

The power of touch

EH Dahl - The Lancet, 2020 - thelancet.com
In his Offline piece, 1 Richard Horton asks whether touch has disappeared from medical
consultations. As a doctor working in Norway, I witness the power of touch daily, from …

[CITATION][C] Our colleagues are working unvaccinated on the front line.

EH Dahl, I Tveter - … for den Norske Laegeforening: Tidsskrift for …, 2021 - europepmc.org
Our colleagues are working unvaccinated on the front line. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

[PDF][PDF] Våre kollegaer står uvaksinerte i frontlinjen

EH Dahl, I Tveter - Kjære kollega, 2021 - tidsskriftet.no
Verdens helseorganisasjon estimerer at mellom 80 000 og 180 000 helsearbeidere har
mistet livet som følge av covid-19 siden starten av pandemien (1). Så langt har ikke …